32
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Photometric and clinical assessment of localized UVB phototherapy systems for the high‐dosage treatment of stable plaque psoriasis

&
Pages 101-106 | Received 13 Jan 2003, Accepted 02 Mar 2003, Published online: 12 Jul 2009

References

  • Lebwohl M Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45: 487–98.
  • Plewig G Hofmann C Braun-Falco O et al. A new apparatus for the delivery of high intensity UVA and UVAzUVB irradiation, and some dermatological applications. Br J Dermatol 1978; 98: 15–24.
  • Bonis B Kemeny L Dobozy et al. 308nm UVB excimer laser for psoriasis. Lancet 1997; 350: 1522.
  • Lotti TM Menchini G Andreassi L. UV-B radiation microphototherapy. An elective treatment for segmental vitiligo. J Eur Acad Dermatol Venereol 1999; 13: 102–8.
  • Asawanonda P Anderson RR Chang Y Taylor CR. 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol 2000; 136: 619–24.
  • Baltas E Nagy P Bonis B et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol 2001; 144: 1266–7.
  • Friedman PM Geronemus RG. Use of the 308-nm excimer laser for postresurfacing leukoderma. Arch Dermatol 2001; 137: 824–5.
  • Mafong EA Friedman PM Kauvar AN et al. Treatment of inverse psoriasis with the 308nm excimer laser. Dermatol Surg 2002; 28: 530–2.
  • Feldman SR Mellen BG Housman TS et al. Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol 2002; 46: 900–6.
  • Trehan M Taylor CR. High-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002; 46: 732–7.
  • Trehan M Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002; 47: 701–8.
  • Adrian RM Parrish JA Momtaz TK Karlin MJ. Outpatient phototherapy for psoriasis. Arch Dermatol 1981; 117: 623–6.
  • Pittelkow MR Perry HO Muller SA et al. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol 1981; 117: 465–8.
  • Larko O Swanbeck G. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol 1982; 62: 507–12.
  • Speight EL Farr PM. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA. Br J Dermatol 1994; 131: 667–72.
  • Rodewald EJ Housman TS Mellen BG Feldman SR. The efficacy of 308nm laser treatment of psoriasis compared to historical controls. Dermatol Online J 2001; 7: 4.
  • Koo J Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51–9.
  • Kemeny L Bonis B Dobozy A et al. 308-nm excimer laser therapy for psoriasis. Arch Dermatol 2001; 137: 95–96.
  • Novak Z Bonis B Baltas E et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T-cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B 2002; 67: 32–8.
  • Chilbert MA Peak MJ Peak JG et al. Effects of intensity and fluence upon DNA single-strand breaks induced by excimer laser radiation. Photochem Photobiol 1988; 47: 523–5.
  • Parrish JA Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359–62.
  • Anderson RR Parrish JA. The optics of human skin. J Invest Dermatol 1981; 77: 13–9.
  • Bruls WA Slaper H van der Leun JC Berrens L. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochem Photobiol 1984; 40: 485–94.
  • Snow JL Muller SA. Surface dosimetry in phototherapy: comparison of three ultraviolet B lamps used in the treatment of psoriasis. Br J Dermatol 1996; 135: 949–54.
  • Housman TS Rohrback JM Fleischer AB, Jr Feldman SR. Phototherapy utilization for psoriasis is declining in the United States. J Am Acad Dermatol 2002; 46: 557–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.